Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

After nearly 18 years on medication to manage her high blood pressure, Charity Wischmeyer, 51, is now discussing with her ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Q2 2025 Results Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSam Fisch - Executive Director, Investor Relations ...

Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...

Why traditional weight loss methods fail to deliver sustainable results—and how Success by Sesame aims to solve that. The science-backed rise of GLP-1 medications and the role of compounded ...

Tracy Byers' experience with semaglutides began dramatically with her first dose, marking a significant turning point in her relationship with food. For the first time in her life, she would ...

In what feels like the biggest health craze in years, weight loss jabs like semaglutide (Ozempic and Wegovy) or tirzepatide (Mounjaro) have exploded in popularity. GP registrar Dr Jack Mosley ...

Semaglutide injections like Ozempic have taken the world by storm—praised for their blood sugar-regulating powers and unintended weight loss effects. But while headlines focus on shrinking ...

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor agonist, has shown promise in promoting weight loss and improving ...